MRI-safe implantable lead
    11.
    发明授权
    MRI-safe implantable lead 有权
    MRI安全可植入引线

    公开(公告)号:US09302101B2

    公开(公告)日:2016-04-05

    申请号:US14215822

    申请日:2014-03-17

    CPC classification number: A61N1/08 A61N1/05 A61N1/0534 A61N1/0553 A61N1/086

    Abstract: A stimulation lead is configured to be implanted into a patient's body and includes at least one distal stimulation electrode and at least one conductive filer electrically coupled to the distal stimulation electrode. A jacket is provided for housing the conductive filer and providing a path distributed along at least a portion of the length of the lead for conducting induced RF energy from the filer to the patient's body.

    Abstract translation: 刺激引线被配置为植入患者体内,并且包括至少一个远端刺激电极和至少一个电连接到远端刺激电极的导电滤波器。 提供外壳以容纳导电滤波器并且提供沿着引线长度的至少一部分分布的路径,以将感应的RF能量从滤波器传导到患者身体。

    Grounding of a shield within an implantable medical lead
    12.
    发明授权
    Grounding of a shield within an implantable medical lead 有权
    在植入式医疗导线内接地护罩

    公开(公告)号:US09272136B2

    公开(公告)日:2016-03-01

    申请号:US14456809

    申请日:2014-08-11

    Abstract: Implantable medical leads include a shield that is guarded at a termination by having a first portion and a second portion of the shield, where the first portion is between a termination of the shield at the second portion and an inner insulation layer that surrounds the filars. The first portion may reduce the coupling of RF energy from the termination of the shield at the second portion to the filars. The first and second portions may be part of a continuous shield, where the first and second portions are separated by an inversion of the shield. The first and second portions may instead be separate pieces. The first portion may be noninverted and reside between the termination at the second portion and the inner layers, or the first portion may be inverted to create first and second sub-portions. The shield termination at the second portion is between the first and second sub-portions.

    Abstract translation: 植入式医疗引线包括通过具有屏蔽件的第一部分和第二部分而在端子处被保护的屏蔽件,其中第一部分位于第二部分处的屏蔽件的终端和围绕线圈的内部绝缘层之间。 第一部分可以减少RF能量从第二部分处的屏蔽端接到丝状体的耦合。 第一和第二部分可以是连续屏蔽的一部分,其中第一和第二部分被屏蔽的反转分开。 第一和第二部分可以是分开的部分。 第一部分可以是非反相的并且位于第二部分的端接部分和内层之间,或者第一部分可以被倒置以产生第一和第二子部分。 第二部分处的屏蔽终端位于第一和第二子部分之间。

    METHODS OF SHIELDING IMPLANTABLE MEDICAL LEADS AND IMPLANTABLE MEDICAL LEAD EXTENSIONS
    14.
    发明申请
    METHODS OF SHIELDING IMPLANTABLE MEDICAL LEADS AND IMPLANTABLE MEDICAL LEAD EXTENSIONS 审中-公开
    屏蔽可植入医疗领域和可植入医疗领域的延伸方法

    公开(公告)号:US20160022983A1

    公开(公告)日:2016-01-28

    申请号:US14804020

    申请日:2015-07-20

    CPC classification number: A61N1/08 A61N1/05 A61N1/086 H01R43/20

    Abstract: A shield layer is added to an existing lead or lead extension by applying the shield layer to the lead body between the proximal contact and distal electrode of the lead body. The shield layer may be covered with an outer insulative layer. An inner insulative layer may be applied over the lead body prior to adding the shield layer and the outer insulative layer. The shield layer may have a terminator applied to the end of the shield layer to prevent migration of the shield layer through the outer insulative layer. The shield layer may be of various forms including a tubular braided wire structure or a tubular foil. The tubular braided wire structure may be applied to the lead body by utilizing the lead body as a mandrel within a braiding machine.

    Abstract translation: 通过将屏蔽层施加到引线主体的近端接触端和远端电极之间的引线体上,将屏蔽层添加到现有的引线或引线延伸部。 屏蔽层可以被外部绝缘层覆盖。 在添加屏蔽层和外部绝缘层之前,可以在引线体上施加内部绝缘层。 屏蔽层可以具有施加到屏蔽层的端部的终止器,以防止屏蔽层通过外部绝缘层的迁移。 屏蔽层可以是各种形式,包括管状编织线结构或管状箔。 管状编织线结构可以通过在编织机中利用引线体作为心轴来施加到引线体。

    Unwrapped 2D view of a stimulation lead with complex electrode array geometry

    公开(公告)号:US10556103B2

    公开(公告)日:2020-02-11

    申请号:US15710571

    申请日:2017-09-20

    Abstract: The disclosure is directed to programming implantable stimulators to deliver stimulation energy via one or more implantable leads having complex electrode array geometries. The disclosure also contemplates guided programming to select electrode combinations and parameter values to support efficacy. The techniques may be applied to a programming interface associated with a clinician programmer, a patient programmer, or both. A user interface permits a user to view electrodes from different perspectives relative to the lead. For example, the user interface provides a side view of a lead and a cross-sectional view of the lead. The user interface may include an axial control medium to select and/or view electrodes at different axial positions along the length of a lead, and a rotational control medium to select and/or view electrodes at different angular positions around a circumference of the lead.

Patent Agency Ranking